PacBio’s mission is to enable the promise of genomics to better human health.
We create some of the world’s most advanced sequencing technologies to provide scientists and clinical researchers the insights to better understand biology and health.
Our products and technology under development stem from two highly differentiated core technologies focused on accuracy, quality and completeness which include our existing HiFi long read sequencing technology and our emerging short read Sequencing by Binding (SBB®) technology. Our products address solutions across a broad set of applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications.
Data Provided by Refinitiv. Minimum 15 minutes delayed.
PacBio to Present at Upcoming Investor Conferences
November 11, 2022
PacBio Announces Third Quarter 2022 Financial Results
November 7, 2022
Recent and Upcoming Events
PacBio Investor Day 2022
November 15, 2022
at 8:15 AM EST
Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
November 17, 2022
at 10:00 AM EST
Evercore ISI 5th Annual HealthCONx Conference
November 29, 2022
at 4:20 PM EST
Piper Sandler 34th Annual Healthcare Conference
December 1, 2022
at 8:00 AM EST